Overview

The Accuracy Of A Novel Platelet Activity Assay In Humans On Antiplatelet Agents: Pharmacodynamics And Comparison With Light Transmission Aggregometry

Status:
Recruiting

Trial end date:
2025-04-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to test a novel diagnostic immunoassay of platelet function and compare it to the current gold standard platelet function assay by testing the response to aspirin and clopidogrel in a group of healthy volunteers and severely obese individuals and comparing the accuracy of the two tests. The secondary goals will be to evaluate the pharmacodynamic parameters of the antiplatelet agents across the two testing modalities and refine the cutoffs used for the novel assay.

Phase:

Early Phase 1

Details

Lead Sponsor:

Beth Israel Deaconess Medical Center

Collaborators:

National Heart, Lung, and Blood Institute (NHLBI)
National Institutes of Health (NIH)

Treatments:

Aspirin
Clopidogrel